| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 6, 2007
Accepted on July 5, 2007
Institut de Génomique Fonctionnelle de Lyon; Université de Lyon; Institut Fédératif Biosciences Gerland Lyon Sud; Université Lyon 1, CNRS, INRA, Ecole Normale Supérieure de Lyon, France; *University of Tübingen, Tübingen Hearing Research Centre, Laboratory of Molecular Neurobiology
* To whom correspondence should be addressed. E-mail: Frederic.Flamant{at}ens-lyon.fr.
Thyroid hormones act directly on transcription by binding to TR
1, TR
1, TR
2 nuclear receptors, regulating many aspects of post-natal development and homeostasis. To precisely analyze the implication of the widely expressed TR
1 isoform in this pleiotropic action, we have generated transgenic mice with a point mutation in the TR
1 coding sequence, which is expressed only after CRE/loxP mediated DNA recombination. The amino-acid change prevents interaction between TR
1 and histone acetyltransferase coactivators and the release of corepressors. Early expression of this dominant-negative receptor deeply affects post-natal development and adult homeostasis, recapitulating many aspects of congenital and adult hypothyroidism, except in tissues and cells where TR
1 and TR
2 are predominantly expressed. Both respective abundance and intrinsic properties of TR
1 and TR
1/2 seems to govern specificity of action.
NURSA Molecule Pages Link:
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |